Evercrisp Biosciences, Inc. has filed for Chapter 11 process to reorganize its rising debts. The biotech research company is backed by Apple Tree Partners (ATP), a life sciences-focused investment ...
SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (BIOR) (“Biora” or the “Company”), a biotech company developing smart pill-based therapeutic platforms, today announced it has ...
ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 ...
Biora Therapeutics announces a Chapter 11 filing to support a sale process and secure up to $10.25 million in financing. Biora Therapeutics, Inc., a biotech company focused on developing smart ...
NEW HAVEN, Conn., Dec. 17 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION), a pharmaceutical company focused on the development of ...
SAN FRANCISCO, March 23, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has ...
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies ...
Dendreon said it has filed for bankruptcy protection as part of a plan to restructure $620 million in debt, a move likely to effectively wipe out the value of its common stock. The biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results